Enorama Pharma AB (ERMA) — Cash Flow Reinvestment Rate
Latest as of December 2015:
0.00x
Enorama Pharma AB (ERMA) has a Cash Flow Reinvestment Rate of 0.00x as of December 2015, reinvesting Skr0.00 (capex Skr0.00 ) from operating cash flow of Skr760.00K. Check ERMA cash to earnings ratio to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
0.00x
(Capex + Investments) / Operating CF
Total Reinvested
Skr0.00
Capex + Investments
Operating Cash Flow
Skr760.00K
SEK
Capital Expenditures
Skr0.00
SEK
Enorama Pharma AB Cash Flow Reinvestment Rate (2014–2015)
Historical reinvestment intensity for Enorama Pharma AB across 2 annual periods. Explore Enorama Pharma AB cash debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
Annual Cash Flow Reinvestment Rate for Enorama Pharma AB (2014–2015)
Year-by-year capital reinvestment analysis for Enorama Pharma AB. For live market cap and broader valuation context, see ERMA market cap.
| Year | Reinvestment Rate | Total Reinvested (SEK) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2015 | 4.15x | Skr1.99 Million | Skr480.00K | Skr1.99 Million | ▼ -7.8% |
| 2014 | 4.50x | Skr1.38 Million | Skr307.00K | Skr1.38 Million | — |
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow